Trials / Active Not Recruiting
Active Not RecruitingNCT05237245
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
Caractérisation Clinico- Biologique et Survie Des Patients Porteurs d'Une lymphoprolifération HTLV-1 Induite (ou Lymphome/leucémie lié au Virus HTLV-1) et Des Patients infectés Par le Virus HTLV-1
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 69 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the outcome (survival) of Adult T-cell leukemia / lymphoma (ATL) patients who receive or not specific treatment for their hemopathy (cohort 1) and the outcome (survival) of HTLV-1 chronically infected patients with / without extra-haematological disorders (cohort 2).
Conditions
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2027-03-01
- Completion
- 2027-03-01
- First posted
- 2022-02-14
- Last updated
- 2026-03-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05237245. Inclusion in this directory is not an endorsement.